Sterile Fluid Path System for On-Site Pharmaceutical QC
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a need for an apparatus that enables accurate and efficient quality control analysis of pharmaceutical products that are prepared on-site or at the point-of-use, particularly for products with short shelf lives like hyperpolarized imaging agents, which require immediate QC to ensure safety and sterility, and must allow for both contact and non-contact measurements.
Innovation Solution
A quality control system comprising a receiver vessel, a sample tube with a one-way valve, and an appendage with chambers to receive and measure pharmaceutical products, along with a sterile fluid path system that includes a vial, dissolution medium, and a tubing system for transferring the product, ensuring sterility and allowing for multiple parameter measurements.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If QC analysis is performed on-site for hyperpolarized imaging agents, then safety and sterility are ensured, but time is lost due to the short shelf life of the product
Solution Approach 1:
The system performs preliminary QC measurements of multiple parameters (pH, temperature, concentration, sterility) before the hyperpolarized imaging agent is administered to the patient. This preliminary action ensures that all necessary quality checks are completed while the product is still viable, preventing time loss during administration.
Solution Approach 2:
The patent replaces traditional contact-based QC measurement methods with non-contact optical measurement techniques. This substitution eliminates contamination risks and reduces measurement time, allowing rapid QC analysis without compromising safety or sterility.
2Reliability
If non-contact QC measurement is used, then sterility is maintained, but measurement capability is limited
Solution Approach 1:
The QC system is designed with multi-functionality to perform both contact and non-contact measurements. It includes optical sensors for non-contact measurements of pH, temperature, and concentration, as well as interfaces for contact-based sterility testing, making it universally applicable to various measurement needs while maintaining sterility.
Solution Approach 2:
The system uses an intermediary optical measurement approach that allows QC analysis without direct contact between the measurement device and the pharmaceutical product. Optical sensors detect parameters through the container walls, serving as an intermediary that maintains sterility while enabling comprehensive measurements.
3Measurement precision
If contact QC measurement is performed, then comprehensive parameter measurement is possible, but contamination risk increases
Solution Approach 1:
The system replaces contact-based mechanical measurement methods with non-contact optical measurement techniques. This substitution maintains measurement precision for parameters like pH, temperature, and concentration while eliminating the contamination risk associated with introducing measurement devices into the pharmaceutical product.
4Reliability
If multiple QC parameters are measured, then product quality is thoroughly assessed, but system complexity increases
Solution Approach 1:
The system merges multiple QC measurement functions (pH measurement, temperature monitoring, concentration analysis, sterility testing) into a single integrated platform. This consolidation allows thorough product quality assessment while managing system complexity through unified hardware and software architecture.
Data Source
AI summary
A quality control system for measuring parameters in a pharmaceutical product includes a receiver vessel to receive a pharmaceutical product therein. The quality control system also includes a sample tube having a first end attached to the receiver vessel to remove pharmaceutical product from the receiver vessel and an appendage connected to a second end of the sample tube. The appendage includes at least one chamber therein to receive a quantity of pharmaceutical product from the receiver vessel. A valve positioned within the sample tube controls flow of the pharmaceutical product to the appendage and prevents flow of the pharmaceutical product from the appendage back into the receiver vessel. The system also includes a quality control device configured to measure at least one parameter of the pharmaceutical product in at least one of the receiver vessel and the appendage.


